Third Harmonic Bio, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has reported a beneficial ownership of 6.52% in Third Harmonic Bio, Inc.'s common stock as of March 31, 2025.
SCHEDULE 13G/A: EcoR1 Capital Divests Entire Stake in Third Harmonic Bio, Filing Amended 13G Showing Zero Ownership
EcoR1 Capital, LLC and its affiliates have reported a complete divestment of their beneficial ownership in Third Harmonic Bio, Inc., now holding 0% of the common stock as of March 31, 2025.
SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose Negligible Stake in Third Harmonics Bio Inc.
FMR LLC and its CEO, Abigail P. Johnson, have filed an amended Schedule 13G, reporting a 0.0% beneficial ownership stake in Third Harmonics Bio Inc. as of March 31, 2025.
Biotechnology Value Fund and its affiliated entities have reported a complete divestment of their beneficial ownership in Third Harmonic Bio, Inc., reducing their stake to 0% as of April 16, 2025.
BML Investment Partners, L.P. has reported a beneficial ownership of 8.3% in Third Harmonic Bio, Inc.'s common stock, totaling 3,724,167 shares, as per a recent Schedule 13G filing.
SCHEDULE 13G: FMR LLC and Abigail P. Johnson Disclose 5.6% Passive Stake in Third Harmonics Bio Inc.
FMR LLC and its affiliate Abigail P. Johnson have filed a Schedule 13G, reporting a passive beneficial ownership of 5.6% of the common stock of Third Harmonics Bio Inc. as of December 31, 2024.